Investment

Details

Chagas disease and Leishmaniasis Screening between DNDi and Daiichi Sankyo Novare
  • RFP Year
    2017
  • Awarded Amount
    $119,000
  • Disease
    NTD (Chagas disease / Leishmaniasis)
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Daiichi Sankyo RD Novare Co., Ltd., Drugs for Neglected Diseases initiative